Illumina NovaSeq X: CeGaT is One of the First Companies to Order Illumina’s New Sequencer
2022, October 03 – Tübingen
2022
2021
CeGaT Breaks Ground for Modern Annex Building
2021, October 27 – Tübingen
2020
CeGaT Presents Results of Corona Antibody Tests
2020, June 27 – Tübingen
2017
CeGaT Obtains CLIA Certification
2017, June 20 – Tübingen
CeGaT Obtains Illumina NovaSeq™ 6000 System
2017, July 5 – Tübingen
2016
CeGaT receives accreditation from the College of American Pathologists (CAP)
2016, June 14 – Tübingen
Significant reduction of turnaround times and prices for genetic diagnostics
2016, May 4 – Tübingen
2014
CAG GmbH - Center for Anmial Genetics: Genetic testing for Horses, Dogs and Cats
2014, October 1 – Tübingen
CeGaT establishes US subsidiary
2014, June 2 – Tübingen/Bethlehem (USA)
CeGaT cooperates with N-of-One on tumor diagnostics
2014, May 28 – Tübingen
Saskia Biskup wins 2014 EU Prize for Women Innovators
2014, March 14 – Tübingen/Brussels (Belgium)
2012
Collaboration between CeGaT and Amplexa
2012, November 16 – Tübingen/Odense (Denmark)
Finalist of the Clarity Challenge
2012, November 7 – Tübingen/Munich/San Francisco (USA)
2011
CeGaT’s Exome Sequencing contributed to a publication in Nature Genetics
2011, November 14 – Tübingen
CeGaT and Genomnia to cooperate on Italian market
2011, September 30 – Tübingen/Milan (Italy)
CeGaT, JSW, and NMI work on novel Alzheimer’s Disease Models
2011, February 18 – Tübingen/Reutlingen/Grambach (Austria)
2010
CeGaT offers fast and cost-efficient Genetic Screening via Next-Generation Sequencing
2010, October 10 – Tübingen
Genetic Diagnostics
Research & Pharma Solutions
CeGaT is a provider of genetic diagnostics and NGS services. The company is based in Tübingen, Germany and is accredited according to CAP, CLIA, DIN EN ISO 15189 and DIN EN ISO 17025.